Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Fallopian Tube Neoplasms × Adenosine Diphosphate Ribose × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 2 fluzoparib 1 Topotecan 1 Surgical Procedures, Operative 1 Poly A 1 Neoadjuvant Therapy 1 Losartan 1 Drug Therapy 1 Doxorubicin 1 Carboplatin 1 Bevacizumab 1 Angiogenesis Inhibitors 1 Albumin-Bound Paclitaxel 1 Adenosine Diphosphate Ribose 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063070 2023-10-02

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

Sun Yat-sen University

Phase 2 Not yet recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡